Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

INDs filed for topical PEP-005

March 26, 2004

New European phase II/III trial for Bexidem in bladder cancer

March 26, 2004

Pamorelin LA receives approval in Germany

March 26, 2004

New tyrosine kinase inhibitors emerge from Merck R&D

March 26, 2004

Novartis and Scripps jointly describe new antitumor epothilones

March 26, 2004

Pfizer describes new CDK2/CDK4 inhibitors with utility in cancer therapy

March 26, 2004

Protective effects of palifermin during chemotherapy/radiotherapy

March 26, 2004

Astex Technology joins BRAF drug discovery collaboration

March 25, 2004

Aplidin enters phase I for pediatric solid tumors and hematological malignancies

March 25, 2004

Novel antitumor protein kinase inhibitors under study at Abbott

March 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...